Evolent Health, Inc. reported $2.10B of revenue over the trailing twelve months, −4.5% on the year before. 10 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $2.10B (to Q2 2026). Net income: −$505M, trailing twelve months to Q2 2026. Operating margin: −23%, trailing twelve months to Q2 2026. EPS: −$4.57, trailing twelve months to Q2 2026.

EVHEvolent Health, Inc.

Healthcare

$3.95-51% 1Y

$3.95

$2.1752 weeks$8.18

EVH as reported

Evolent Health, Inc. reported $2.10B of revenue over the trailing twelve months, −4.5% on the year before. 10 reported series are charted on this page, each one as filed.

$2.10B

Revenue, trailing twelve months · to Q2 2026 · −4.5% against the twelve months before

Net income: −$505M
Net income · +287% year on year · trailing twelve months to Q2 2026
Operating margin: −23%
Operating margin · trailing twelve months to Q2 2026
EPS: −$4.57
EPS · +184% year on year · trailing twelve months to Q2 2026

Details›

Every series Ryufin has for EVH, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$2.10B	−4.5%	Q2 2026
Net income	−$505M	+287%	Q2 2026
EPS	−$4.57	+184%	Q2 2026
Gross margin	18%	n/a	Q2 2026
Operating margin	−23%	n/a	Q2 2026
Net margin	−26%	n/a	Q2 2026
ROE	−100%	n/a	Q2 2026
ROA	−21%	n/a	Q2 2026
ROIC	−20%	n/a	Q2 2026
Free cash flow	−$78M	n/a	Q4 2019 · 26 quarters behind

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.